HomeCompareLIOPY vs PLD

LIOPY vs PLD: Dividend Comparison 2026

LIOPY yields 1.43% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.46M in total portfolio value
10 years
LIOPY
LIOPY
● Live price
1.43%
Share price
$16.40
Annual div
$0.23
5Y div CAGR
38.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.2K
Annual income
$6,267.32
Full LIOPY calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — LIOPY vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIOPYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIOPY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIOPY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIOPY
Annual income on $10K today (after 15% tax)
$121.42/yr
After 10yr DRIP, annual income (after tax)
$5,327.22/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,462,643.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIOPY + PLD for your $10,000?

LIOPY: 50%PLD: 50%
100% PLD50/50100% LIOPY
Portfolio after 10yr
$3.27M
Annual income
$2,631,351.75/yr
Blended yield
80.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

LIOPY
No analyst data
Altman Z
3.1
Piotroski
8/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIOPY buys
0
PLD buys
0
No recent congressional trades found for LIOPY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIOPYPLD
Forward yield1.43%3.18%
Annual dividend / share$0.23$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.2%74.4%
Portfolio after 10y$40.2K$6.50M
Annual income after 10y$6,267.32$5,256,436.18
Total dividends collected$17.9K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LIOPY vs PLD ($10,000, DRIP)

YearLIOPY PortfolioLIOPY Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,897$197.41$11,255$555.24$358.00PLD
2$11,938$277.85$13,062$1,018.59$1.1KPLD
3$13,167$393.14$15,903$1,926.67$2.7KPLD
4$14,649$560.04$20,839$3,823.32$6.2KPLD
5$16,479$804.74$30,464$8,166.08$14.0KPLD
6$18,802$1,169.25$52,054$19,457.30$33.3KPLD
7$21,841$1,723.06$109,886$54,188.93$88.0KPLD
8$25,955$2,585.22$304,030$186,451.18$278.1KPLD
9$31,740$3,968.01$1,166,125$840,813.32$1.13MPLD
10$40,229$6,267.32$6,504,190$5,256,436.18$6.46MPLD

LIOPY vs PLD: Complete Analysis 2026

LIOPYStock

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.

Full LIOPY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this LIOPY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIOPY vs SCHDLIOPY vs JEPILIOPY vs OLIOPY vs KOLIOPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.